Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glyceraldehyde-3-phosphate dehydrogenase pseudogene 38 (GAPDHP38) is one of many pseudogenes in the human genome with sequence similarity to the functional GAPDH gene. Pseudogenes are non-functional DNA sequences derived from functional parental genes and generally do not produce functional proteins. These genes are not considered therapeutic targets or relevant to drug development. While the protein-coding GAPDH is an enzyme active in glycolysis and involved in numerous cellular processes and disease states, GAPDHP38 itself does not serve any known biological or clinical function[4]. If you seek information about the functional enzyme and established therapeutic target, refer to Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) instead[1][2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glyceraldehyde-3-phosphate dehydrogenase pseudogene 38 (GAPDHP38).